Immune checkpoint inhibitor target found to promote skin cancer growth

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.

source https://www.news-medical.net/news/20240119/Immune-checkpoint-inhibitor-target-found-to-promote-skin-cancer-growth.aspx

Comments

Popular posts from this blog

New and surprising evidence that ChatGPT can perform several intricate tasks relevant to handling complex medical and clinical information

"Deep sequencing" of the genome informs diagnoses and treatment of vascular anomalies